Literature DB >> 34985655

An In Vitro System to Model the Establishment and Reactivation of HIV-1 Latency in Primary Human CD4+ T Cells.

Rui Li1, Fabio Romerio2.   

Abstract

HIV-1 establishes latency primarily by infecting activated CD4+ T cells that later return to quiescence as memory cells. Latency allows HIV-1 to evade immune responses and to persist during antiretroviral therapy, which represents an important problem in clinical practice. Here we describe both the original and a simplified version of HIV-1 latency models that mimics this process using replication competent viruses. Our model allows generation of large numbers of latently infected CD4+ T cell to dissect molecular mechanisms of HIV latency and reactivation.
© 2022. Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  CD4+ T cells; HIV-1; Latency; Monocyte-derived dendritic cells

Mesh:

Year:  2022        PMID: 34985655     DOI: 10.1007/978-1-0716-1871-4_3

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  20 in total

Review 1.  In vivo activation of antigen-specific CD4 T cells.

Authors:  M K Jenkins; A Khoruts; E Ingulli; D L Mueller; S J McSorley; R L Reinhardt; A Itano; K A Pape
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

2.  Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy.

Authors:  D Finzi; J Blankson; J D Siliciano; J B Margolick; K Chadwick; T Pierson; K Smith; J Lisziewicz; F Lori; C Flexner; T C Quinn; R E Chaisson; E Rosenberg; B Walker; S Gange; J Gallant; R F Siliciano
Journal:  Nat Med       Date:  1999-05       Impact factor: 53.440

Review 3.  Control of T cell viability.

Authors:  Philippa Marrack; John Kappler
Journal:  Annu Rev Immunol       Date:  2004       Impact factor: 28.527

4.  Models of HIV-1 persistence in the CD4+ T cell compartment: past, present and future.

Authors:  Mudit Tyagi; Fabio Romerio
Journal:  Curr HIV Res       Date:  2011-12-01       Impact factor: 1.581

Review 5.  Experimental approaches to the study of HIV-1 latency.

Authors:  Yefei Han; Megan Wind-Rotolo; Hung-Chih Yang; Janet D Siliciano; Robert F Siliciano
Journal:  Nat Rev Microbiol       Date:  2007-02       Impact factor: 60.633

6.  Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy.

Authors:  T W Chun; L Stuyver; S B Mizell; L A Ehler; J A Mican; M Baseler; A L Lloyd; M A Nowak; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

7.  Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy.

Authors:  D Finzi; M Hermankova; T Pierson; L M Carruth; C Buck; R E Chaisson; T C Quinn; K Chadwick; J Margolick; R Brookmeyer; J Gallant; M Markowitz; D D Ho; D D Richman; R F Siliciano
Journal:  Science       Date:  1997-11-14       Impact factor: 47.728

8.  Detection of lymphocytes expressing human T-lymphotropic virus type III in lymph nodes and peripheral blood from infected individuals by in situ hybridization.

Authors:  M E Harper; L M Marselle; R C Gallo; F Wong-Staal
Journal:  Proc Natl Acad Sci U S A       Date:  1986-02       Impact factor: 11.205

9.  Recovery of replication-competent HIV despite prolonged suppression of plasma viremia.

Authors:  J K Wong; M Hezareh; H F Günthard; D V Havlir; C C Ignacio; C A Spina; D D Richman
Journal:  Science       Date:  1997-11-14       Impact factor: 47.728

10.  In vivo fate of HIV-1-infected T cells: quantitative analysis of the transition to stable latency.

Authors:  T W Chun; D Finzi; J Margolick; K Chadwick; D Schwartz; R F Siliciano
Journal:  Nat Med       Date:  1995-12       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.